595 PROSPECTIVE, RANDOMIZED, COMPARATIVE STUDY OF HIGH DOSE INTRAVESICAL EPIRUBICIN VERSUS BCG FOR PROPHYLAXIS IN INTERMEDIATE RISK SUPERFICIAL BLADDER TUMORS

Autor: Moutzouris, G., Lykourinas, M., Malovrouvas, D., Tsolos, C., Michail, E., Gezerlis, I., Melekos, M., Dimitriadis, I.
Zdroj: In European Urology Supplements 2007 6(2):171-171
Databáze: ScienceDirect